Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has announcements × Various Advanced Cancer × Cisplatin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 12 Parkinson Disease 4, Autosomal Dominant Lewy Body 7 Uterine Cervical Neoplasms 2 Urothelial Cancer 2 Urinary Bladder Neoplasms 2 Mesothelioma 2 Head and Neck Neoplasms 2 Carcinoma 2 Various Advanced Cancer 1 Urologic Neoplasms 1 Urethral Neoplasms 1 Ureteral Neoplasms 1 Stomach Neoplasms 1 Small Cell Lung Carcinoma 1 Ototoxicity 1 Non-Squamous Non-Small Cell Lung Cancer, Squamous Non-Small Cell Lung Cancer 1 Non Small Cell Lung Cancer NSCLC 1 Neoplasm Metastasis 1 Nasopharyngeal Carcinoma 1 Metastatic Urothelial Cancer 1 Lung Neoplasms 1 Liver Neoplasms 1 Hepatoblastoma 1 Gallbladder Neoplasms 1 Esophageal Neoplasms 1 Cholangiocarcinoma 1 Carcinoma, Transitional Cell 1 Bile Duct Neoplasms 1 Adenocarcinoma of Lung 1 Adenocarcinoma 1

Interventions

Nivolumab 2 Ipilimumab 1 Fluorouracil 1 Cisplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03143153 2026-02-17

CheckMate 648

Bristol-Myers Squibb

Phase 3 Completed

970 enrolled 15 charts 1 FDA

Various Advanced Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡